MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Clinical trials for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists use Super-Powerful MRI to test new MS pill
Disease control Not yet recruitingThis 2-year study is testing the drug remibrutinib in about 20 people with relapsing or progressive multiple sclerosis (MS). The main goal is to use a very powerful, specialized MRI scanner to see detailed changes in the brain over time. Researchers will also monitor the drug's s…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: PHASE2 • Sponsor: Moein Amin • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Common supplement could help control MS symptoms
Disease control Not yet recruitingThis study is testing whether adding taurine supplements to standard multiple sclerosis medications helps control the disease better. Researchers will follow 80 adults with MS for two years to see if taurine reduces new brain lesions, lowers relapse rates, and slows disability pr…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: PHASE2 • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists test 'Living Drug' to reset immune system in MS patients
Disease control Not yet recruitingThis early-stage study is testing a new personalized therapy called CABA-201 for adults with multiple sclerosis (MS) that hasn't responded well to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to target the cells thought to drive MS, an…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Simple blood test could replace frequent MRIs for MS patients
Disease control Not yet recruitingThis study is testing if a simple monthly blood test can spot hidden disease activity in people with relapsing-remitting multiple sclerosis (MS) earlier than the standard yearly MRI scans. Researchers will compare two groups: one gets the new monthly blood monitoring, while the o…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC
-
Mind over MS: can thinking about movement and balance training ease symptoms?
Symptom relief Not yet recruitingThis study is testing a new combination of two therapies for people with relapsing-remitting multiple sclerosis (MS). It combines 'motor imagery,' which is mentally practicing movements, with 'vestibular rehabilitation,' which is exercises to improve balance and reduce dizziness.…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: Medipol University • Aim: Symptom relief
Last updated Mar 23, 2026 15:15 UTC
-
Eye scans could reveal hidden clues to MS treatment success
Knowledge-focused Not yet recruitingThis study aims to find new signs in eye scans that show how the multiple sclerosis (MS) drug ublituximab is working inside the body. Researchers will enroll 30 people with relapsing MS—half starting the drug and half on other stable treatments—and perform special eye scans over …
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC